Skip to main content

Tokyo Office Presents “Maximizing Value from Strategic Partnering in Clinical Development”

BOSTON – March 8, 2019 Greenberg Traurig, LLP’s Tokyo office hosted the seminar, “Maximizing Value from Strategic Partnering in Clinical Development,” on March 1, 2019. The program took an in-depth look at the life-cycle of an early stage biotech company that has developed an exciting new drug candidate and looked to commercialize the product through strategic partnerships. The event was co-hosted by Catenion, a pharmaceutical and medical products management consulting firm.

Speakers from Greenberg Traurig and Catenion discussed how successful partnering relationships are cultivated, negotiated, and implemented. Specific topics included:

  • Understanding your transaction options
    • Type of partner
    • Geographic scope
    • Collaboration vs out-licensing
    • Best value inflection point for partnering
    • Scope of Partnering (asset vs indication, etc.)
  • The impact of a sound IP strategy on value and commercialization opportunities
  • Key issues in negotiating your term sheets and definitive agreements
  • Avoiding the pitfalls – when and why deals go bad
  • Once the deal is signed – the real work begins!

Co-Chair of Greenberg Traurig’s Japan Practice Koichiro Ohashi delivered the program's opening remarks. Other speakers included:

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: Twitter: @GT_Law.